Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay Guido Capone

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Behavioural Neurology|April 30, 2003
Upper and lower face and ideomotor apraxia in patients with Alzheimer's diseaseJay Guido Capone, Sergio Della Sala, Hans Spinnler, et al.
The Journal of Headache and Pain|December 20, 2005
CGRP and migraine: neurogenic inflammation revisitedPierangelo Geppetti, Jay Guido Capone, Marcello Trevisani, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 30, 2023
Idiopathic cervical dystonia and non-motor symptoms: a pilot case-control study on autonomic nervous systemFabiana Colucci, Maura Pugliatti, Ilaria Casetta, et al.
Pain|December 30, 2006
Botulinum toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skinValeria Tugnoli, Jay Guido Capone, Roberto Eleopra, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|May 14, 2025
Global improvement after deep brain stimulation in Parkinson's disease: Comparison between patient and clinician perspectivesPietro Antenucci, Fabiana Colucci, Andrea Gozzi, et al.
Cerebellum (London, England)|July 10, 2025
Sex Differences in Spinocerebellar Ataxia Type 1: Clinical Presentation and ProgressionFabiana Colucci, Sara Stefanelli, Elena Contaldi, et al.
Frontiers in Public Health|February 9, 2026
Budget impact analysis of deep brain stimulation devices with different longevity in Parkinson's disease: insights from real-world dataMariachiara Sensi, Pietro Antenucci, Fabiana Colucci, et al.
Movement Disorders Clinical Practice|July 15, 2025
Opicapone in Parkinson's Disease on Levodopa-Carbidopa Intestinal Gel Treatment: A Pilot, Randomized StudyFabiana Colucci, Andrea Gozzi, Pietro Antenucci, et al.
Movement Disorders Clinical Practice|February 14, 2026
Risk-Benefit Considerations in Deep Brain Stimulation Discontinuation for Late-Stage Parkinson's DiseasePietro Antenucci, Andrea Gozzi, Fabiana Colucci, et al.
Journal of Clinical Medicine|August 29, 2024
Cognition in Patients with Spinocerebellar Ataxia 1 (SCA1) and 2 (SCA2): A Neurophysiological and Neuropsychological ApproachFabiana Colucci, Sara Stefanelli, Elena Contaldi, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Behavioural Neurology|April 30, 2003
Upper and lower face and ideomotor apraxia in patients with Alzheimer's diseaseJay Guido Capone, Sergio Della Sala, Hans Spinnler, et al.
The Journal of Headache and Pain|December 20, 2005
CGRP and migraine: neurogenic inflammation revisitedPierangelo Geppetti, Jay Guido Capone, Marcello Trevisani, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 30, 2023
Idiopathic cervical dystonia and non-motor symptoms: a pilot case-control study on autonomic nervous systemFabiana Colucci, Maura Pugliatti, Ilaria Casetta, et al.
Pain|December 30, 2006
Botulinum toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skinValeria Tugnoli, Jay Guido Capone, Roberto Eleopra, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|May 14, 2025
Global improvement after deep brain stimulation in Parkinson's disease: Comparison between patient and clinician perspectivesPietro Antenucci, Fabiana Colucci, Andrea Gozzi, et al.
Cerebellum (London, England)|July 10, 2025
Sex Differences in Spinocerebellar Ataxia Type 1: Clinical Presentation and ProgressionFabiana Colucci, Sara Stefanelli, Elena Contaldi, et al.
Frontiers in Public Health|February 9, 2026
Budget impact analysis of deep brain stimulation devices with different longevity in Parkinson's disease: insights from real-world dataMariachiara Sensi, Pietro Antenucci, Fabiana Colucci, et al.
Movement Disorders Clinical Practice|July 15, 2025
Opicapone in Parkinson's Disease on Levodopa-Carbidopa Intestinal Gel Treatment: A Pilot, Randomized StudyFabiana Colucci, Andrea Gozzi, Pietro Antenucci, et al.
Movement Disorders Clinical Practice|February 14, 2026
Risk-Benefit Considerations in Deep Brain Stimulation Discontinuation for Late-Stage Parkinson's DiseasePietro Antenucci, Andrea Gozzi, Fabiana Colucci, et al.
Journal of Clinical Medicine|August 29, 2024
Cognition in Patients with Spinocerebellar Ataxia 1 (SCA1) and 2 (SCA2): A Neurophysiological and Neuropsychological ApproachFabiana Colucci, Sara Stefanelli, Elena Contaldi, et al.
Pageof 2